Publication 1/07/2021

CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice.

Schmid RS, Deng X, Panikker P, Msackyi M, Breton C, Wilson JM

The Journal Of Clinical Investigation